The proportion of heart attack patients who are 40 or younger has steadily increased over the last decade, according to research set to be presented March 17 at the American College of Cardiology’s scientific sessions in New Orleans.

To conquer STEMI’s “last frontier,” cardiologists are tapping into an evolving arsenal of strategies while calling for more data and standardized definitions to guide treating physicians.

A new stem cell-based test may add certainty to efforts to predict whether so-called variants of uncertain significance will contribute to the development of diseases or be harmless. 

Tracking patients’ changes in fractional flow reserve (FFR) from before to after a percutaneous coronary intervention (PCI) may provide useful information, according to new research published in JAMA Cardiology. Individuals with the greatest change in FFR were less likely to experience vessel-related events and demonstrated greater symptomatic relief.

By the time three transplant physicians approached Tom Giangiulio Jr. about being the first patient in a new clinical trial to accept a heart from a Hepatitis C-positive donor, Giangiulio didn’t have much of a choice.

Patients who remain in the hospital for longer than three days following transcatheter aortic valve replacement (TAVR) are at a 45 percent increased risk of death within one year versus those discharged sooner after the procedure, a new analysis found.

The Early Bird Bleed Monitoring System, which can detect internal bleeding during endovascular procedures, has been granted de novo classification by the FDA. The approval was announced March 5 by Saranas, the device’s manufacturer.

In its first scientific statement on accurately measuring blood pressure in 14 years, the American Heart Association gave a stronger recommendation for oscillometric devices and updated the evidence surrounding ambulatory and home blood pressure monitoring techniques.